CEBPZ and prostate neoplasm: We analyzed high-coverage tumor-normal matched WGS data from 162 individuals across eight tumor types, including 19 childhood acute lymphoblastic leukemia samples (ALL, phs000341) [24], 36 medulloblastoma samples (phs000409) [25], 16 core-binding factor acute myeloid leukemia samples (CBF-AML, phs000414), 40 prostatic neoplasm samples (phs000447) [26], 12 AIDS-related lymphoma samples (phs000530), 12 intestinal neoplasm samples (Liver/Small bowel, phs000579) [27], 13 osteosarcoma samples (phs000699) [28], and 14 esophageal adenocarcinoma samples (phs000598) [29].